Protein profile

VK055_1703

short chain dehydrogenase family protein

Genome: KpATCC43816

Gene: AIK80323.1 Structure source: AlphaFold + ColabFold UniProt A0A0H3GUF6
Amino acids 249
Annotations 3
Features 25
PDB binders 3
Druggability 0.766

Overview

Basic information about this protein and its source genome.

Accession
VK055_1703
Gene
AIK80323.1
Status
annotated
Amino acids
249
Structure source
AlphaFold + ColabFold

Target profile

Computed evidence for target prioritization.

Human off-target
hit
Human identity (%)
41.333
Human E-value
1.86e-06
Gut microbiome off-target
hit
Essential (DEG)
Y
DEG identity (%)
44.177
DEG E-value
5.48e-53
Localization
Cytoplasmic
ColabFold pLDDT
96.36

Selected Druggability evidence

AlphaFold / UniProt model

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.766
Structure A0A0H3GUF6
Pocket Pocket 1
P2Rank 0.873
Structure A0A0H3GUF6
Pocket Pocket 1
ColabFold model
FPocket 0.799 · Pocket 3
P2Rank 0.888 · Pocket 1
Core conservation Conserved core gene
Roary core
CoreCruncher core
Gut microbiome 27 / 4744 genomes with a hit
Normalized 0.006

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

3 GO

Gene Ontology (GO)

3
  • GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
  • GO:0016616 Catalysis of an oxidation-reduction (redox) reaction in which a CH-OH group acts as a hydrogen or electron donor and reduces NAD+ or NADP.
  • GO:0030497 The elongation of a fatty acid chain by the sequential addition of two-carbon units.

Sequence Features

Domain/signature hits from InterPro and related databases.

25 records
Show feature table
Start End DB Term Name
2 246 PANTHER PTHR42760 SHORT-CHAIN DEHYDROGENASES/REDUCTASES FAMILY MEMBER
80 91 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
80 91 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
127 143 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
127 143 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
155 174 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
155 174 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
176 193 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
176 193 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
7 24 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
7 24 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
210 230 PRINTS PR00081 Glucose/ribitol dehydrogenase family signature
210 230 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
6 186 SMART SM00822 This enzymatic domain is part of bacterial polyketide synthases and catalyses the first step in the reductive modification of the beta-carbonyl centres in the growing polyketide chain. It uses NADPH to reduce the keto group to a hydroxy group.
1 249 FunFam G3DSA:3.40.50.720:FF:000084 Short-chain dehydrogenase reductase
133 141 PRINTS PR00080 Short-chain dehydrogenase/reductase (SDR) superfamily signature
133 141 InterPro IPR002347 Short-chain dehydrogenase/reductase SDR
155 174 PRINTS PR00080 Short-chain dehydrogenase/reductase (SDR) superfamily signature
80 91 PRINTS PR00080 Short-chain dehydrogenase/reductase (SDR) superfamily signature
142 170 ProSitePatterns PS00061 Short-chain dehydrogenases/reductases family signature.
142 170 InterPro IPR020904 Short-chain dehydrogenase/reductase, conserved site
12 246 Pfam PF13561 Enoyl-(Acyl carrier protein) reductase
2 249 Gene3D G3DSA:3.40.50.720 -
4 248 SUPERFAMILY SSF51735 NAD(P)-binding Rossmann-fold domains
4 248 InterPro IPR036291 NAD(P)-binding domain superfamily

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 2

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold AF_A0A0H3GUF6
AlphaFold full sequence Viewing
ColabFold VK055_1703
ColabFold full sequence Loaded
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
1 0.766

Pockets (P2RANK)

Showing top-ranked P2Rank candidates by probability. Probability is color-coded per P2Rank calibration: high (≥ 0.5), medium (0.2 – 0.49), low (< 0.2).

P2RANK Sticks Spheres Surfaces Score Probability Labels Zoom Positions
1 12.22 0.643
2 3.73 0.143
3 1.22 0.011

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

58 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
B3P B3R6T4 282.3 Da LogP -4.01 TPSA 145.4 1 viol. ✓ Clean C(CNC(CO)(CO)CO)CNC(CO)(CO)CO
MLH V5VHN7 417.3 Da LogP 4.34 TPSA 54.7 ✓ Ro5 ✓ Clean CCOC(=O)c1c2cc(c(cc2n(c1CN(C)C)c3ccccc3)Br)O
RM4 C1DMX5 164.2 Da LogP -2.19 TPSA 90.2 ✓ Ro5 ✓ Clean C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)O)O)O)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.